Stelara Sales Data
| Rank 81 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Stelara U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 81 ( 12) |
$201,950 | 10.71% | 24 | 4.35% |
| Q4 2012 | 93 (7) |
$182,409 | 7.52% | 23 | 4.55% |
| Q3 2012 | 100 ( ) |
$169,648 |  |
22 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|---|
| August 23, 2011 | Injectable Psoriasis Drugs May Not Hike Heart Risks: Study |
| January 13, 2010 | Newer Drug More Effective in Psoriasis Treatment |
| September 25, 2009 | Stelara Approved for Psoriasis |
